Silica-polymer composites as the novel antibiotic delivery systems for bone tissue infection
pl
dc.type
JournalArticle
pl
dc.identifier.weblink
https://www.mdpi.com/1999-4923/12/1/28/htm
pl
dc.abstract.en
Bone tissue inflammation, osteomyelitis, is commonly caused by bacterial invasion and requires prolonged antibiotic therapy for weeks or months. Thus, the aim of this study was to develop novel silica-polymer local bone antibiotic delivery systems characterized by a sustained release of ciprofloxacin (CIP) which remain active against Staphylococcus aureus for a few weeks, and do not have a toxic effect towards human osteoblasts. Four formulations composed of ethylcellulose (EC), polydimethylsiloxane (PDMS), freeze-dried CIP, and CIP-adsorbed mesoporous silica materials (MCM-41-CIP) were prepared via solvent-evaporation blending method. All obtained composites were characterized in terms of molecular structure, morphological, and structural properties by using Fourier Transform Infrared Spectroscopy (FTIR), scanning electron microscopy equipped with energy-dispersive X-ray spectroscopy (SEM/EDX), and X-ray diffraction (XRD), thermal stability by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), and in vitro antibiotic release. The antibacterial activity against Staphylococcus aureus (ATCC 6538) as well as the in vitro cytocompatibility to human osteoblasts of obtained composites were also examined. Physicochemical results confirmed the presence of particular components (FTIR), formation of continuous polymer phase onto the surface of freeze-dried CIP or MCM-41-CIP (SEM/EDX), and semi-crystalline (composites containing freeze-dried CIP) or amorphous (composites containing MCM-41-CIP) structure (XRD). TGA and DSC analysis indicated the high thermal stability of CIP adsorbed onto the MCM-41, and higher after MCM-41-CIP coating with polymer blend. The release study revealed the significant reduction in initial burst of CIP for the composites which contained MCM-41-CIP instead of freeze-dried CIP. These composites were also characterized by the 30-day activity against S. aureus and the highest cytocompatibility to human osteoblasts in vitro.
pl
dc.subject.en
drug delivery system
pl
dc.subject.en
mesoporous silica
pl
dc.subject.en
silica-polymer
pl
dc.subject.en
ciprofloxacin
pl
dc.subject.en
polydimethylsiloxane
pl
dc.subject.en
composites
pl
dc.subject.en
coating blend
pl
dc.description.volume
12
pl
dc.description.number
1
pl
dc.description.publication
2,3
pl
dc.identifier.doi
10.3390/pharmaceutics12010028
pl
dc.identifier.eissn
1999-4923
pl
dc.title.journal
Pharmaceutics
pl
dc.language.container
eng
pl
dc.date.accession
2020-06-15
pl
dc.affiliation
Wydział Chemii : Zakład Technologii Chemicznej
pl
dc.subtype
Article
pl
dc.identifier.articleid
28
pl
dc.rights.original
CC-BY; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0